Investing.com -- Goldman Sachs downgraded shares of General Mills (NYSE: GIS) and Conagra Brands (NYSE: CAG ), citing ongoing ...

The downgrade reflects Vivid Seats’ weaker than expected performance due to a sharp increase in competition. The increased marketing spend by competitors via third-party search engines has led to a ...

Moody’s Ratings has elevated the issuer and senior unsecured ratings of Central Japan Railway Company (JR Central) from A2 to A1, and altered the outlook from positive to stable. The rating upgrade is ...

Universal Entertainment’s consolidated EBITDA is expected to recover from ¥21.2 billion in fiscal 2024 to about ¥29 billion this fiscal year, which is about 70% of the EBITDA recorded in a relatively ...

ArcelorMittal has been active in reshaping its asset portfolio, including strategic acquisitions and expansion in the North American market to reduce exposure to potential tariffs. The company has ...

Ratings has upgraded its long-term issuer credit rating for online travel agency eDreams ODIGEO S.A. to ’B+’ from ’B’. This upgrade follows eDreams’ strong operating performance for fiscal 2025, which ...

The short seller’s analysis also calls into question GRAIL’s claims of the Galleri test’s positive predictive value (PPV), suggesting that the company’s comparisons to standard screening tools are ...

Joe Ovsenek, President and CEO of Tudor Gold, stated, "Our acquisition of American Creek cements our interest in the Treaty Creek Project, which hosts one of the largest gold discoveries in Canada ...

Corp to Equal-weight from Overweight, saying the fast-food giant’s stock already reflects much of its near-term improvement, ...

Shares of Plug Power Inc (NASDAQ:PLUG) surged 8.3% following the announcement of a significant expansion of its partnership ...

Shares of Ondas Holdings Inc. (NASDAQ:ONDS) surged 11.2% following the announcement of a substantial $14.3 million purchase order from a key defense customer for multiple units of its Optimus System, ...

Shares of PolyPid Ltd. (NASDAQ: PYPD) soared 10.1% following the announcement of positive Phase 3 trial results for its D-PLEX100 product, aimed at preventing sur ...